Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.65 - $1.1 $10,701 - $18,110
16,464 Added 12.31%
150,211 $123,000
Q4 2022

Feb 13, 2023

SELL
$0.48 - $0.88 $2,477 - $4,542
-5,162 Reduced 3.72%
133,747 $88,000
Q3 2022

Nov 14, 2022

SELL
$0.79 - $22.0 $127 - $3,564
-162 Reduced 0.12%
138,909 $120,000
Q2 2022

Aug 12, 2022

SELL
$0.8 - $1.5 $417,443 - $782,706
-521,804 Reduced 78.96%
139,071 $116,000
Q1 2022

May 13, 2022

SELL
$1.24 - $2.75 $27,785 - $61,622
-22,408 Reduced 3.28%
660,875 $899,000
Q4 2021

Feb 08, 2022

BUY
$2.42 - $3.65 $35,017 - $52,815
14,470 Added 2.16%
683,283 $1.71 Million
Q3 2021

Nov 15, 2021

SELL
$2.82 - $3.7 $138,439 - $181,640
-49,092 Reduced 6.84%
668,813 $2.15 Million
Q2 2021

Aug 13, 2021

SELL
$3.5 - $5.48 $2,866 - $4,488
-819 Reduced 0.11%
717,905 $2.56 Million
Q1 2021

May 12, 2021

SELL
$3.16 - $4.89 $82,615 - $127,844
-26,144 Reduced 3.51%
718,724 $2.54 Million
Q4 2020

Feb 11, 2021

BUY
$2.2 - $4.45 $73,972 - $149,626
33,624 Added 4.73%
744,868 $2.36 Million
Q3 2020

Nov 16, 2020

BUY
$2.62 - $4.78 $21,559 - $39,334
8,229 Added 1.17%
711,244 $2.87 Million
Q2 2020

Aug 14, 2020

BUY
$1.83 - $3.16 $1.04 Million - $1.79 Million
566,352 Added 414.42%
703,015 $1.88 Million
Q1 2020

May 14, 2020

BUY
$1.14 - $2.96 $31,314 - $81,308
27,469 Added 25.16%
136,663 $259,000
Q4 2019

Feb 14, 2020

BUY
$1.25 - $2.57 $5,216 - $10,724
4,173 Added 3.97%
109,194 $281,000
Q3 2019

Nov 13, 2019

SELL
$1.26 - $1.96 $404,970 - $629,953
-321,405 Reduced 75.37%
105,021 $149,000
Q2 2019

Aug 13, 2019

SELL
$1.43 - $1.94 $29,362 - $39,834
-20,533 Reduced 4.59%
426,426 $640,000
Q1 2019

May 13, 2019

BUY
$0.94 - $2.47 $54,102 - $142,163
57,556 Added 14.78%
446,959 $795,000
Q4 2018

Feb 12, 2019

BUY
$0.57 - $1.53 $1,764 - $4,735
3,095 Added 0.8%
389,403 $335,000
Q3 2018

Nov 14, 2018

BUY
$1.44 - $3.13 $12,185 - $26,486
8,462 Added 2.24%
386,308 $618,000
Q2 2018

Sep 18, 2018

SELL
$2.92 - $5.1 $7,145 - $12,479
-2,447 Reduced 0.64%
377,846 $1.13 Million
Q2 2018

Aug 14, 2018

SELL
$2.92 - $5.1 $78,381 - $136,899
-26,843 Reduced 6.59%
380,293 $1.13 Million
Q1 2018

May 09, 2018

SELL
$3.42 - $5.35 $119 - $187
-35 Reduced 0.01%
407,136 $1.85 Million
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.84 $67,941 - $100,870
20,841 Added 5.39%
407,171 $1.63 Million
Q3 2017

Nov 13, 2017

BUY
$3.83 - $4.89 $1.48 Million - $1.89 Million
386,330
386,330 $1.71 Million

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.